Related Experiment Video
Updated: Jul 3, 2026
13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Hereditary ovarian cancer.
Antonio Russo1, Valentina Calò, Loredana Bruno
1Department of Surgery and Oncology, Regional Reference Center for the Biomolecular Characterization and Genetic Screening of Hereditary Tumors, Università di Palermo, Palermo, Italy. lab-oncobiologia@usa.net
Critical Reviews in Oncology/Hematology
|July 29, 2008
Summary
Hereditary ovarian cancer, often due to BRCA mutations, affects over 10% of cases. Genetic testing and surveillance, including ultrasounds and CA125, are crucial for high-risk individuals.
Area of Science:
- Oncology
- Genetics
- Gynecology
Background:
- Hereditary factors contribute to at least 10% of ovarian tumors.
- Key hereditary ovarian cancer syndromes include site-specific, hereditary breast and/or ovarian cancer (HBOC), and hereditary non-polyposis colorectal cancer (HNPCC).
- BRCA mutations are responsible for over 90% of hereditary epithelial ovarian tumors, while MLH1 and MSH2 mutations are linked to HNPCC.
Purpose of the Study:
- To outline the genetic basis of hereditary ovarian cancer.
- To describe available genetic testing and surveillance strategies.
- To discuss risk-reducing surgical options for high-risk populations.
Main Methods:
- Review of genetic predispositions for ovarian cancer.
- Description of clinical manifestations and associated genes (BRCA, MLH1, MSH2).
- Summary of current surveillance protocols and surgical interventions.
Main Results:
- BRCA mutations are the primary cause of hereditary ovarian cancer.
- Genetic testing is available for HBOC and HNPCC syndromes.
- Surveillance recommendations include regular ultrasound and CA125 testing for high-risk women.
- Bilateral salpingo-oophorectomy is effective in reducing ovarian cancer risk for BRCA carriers.
- Hysterosalpingo-oophorectomy is recommended for HNPCC patients undergoing colorectal surgery.
Conclusions:
- Understanding genetic predispositions is vital for managing hereditary ovarian cancer.
- Genetic testing, surveillance, and prophylactic surgery are key strategies for risk reduction.
- Personalized management approaches are necessary for different hereditary ovarian cancer syndromes.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:22Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...